Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1996 May;55(5):273–275. doi: 10.1136/ard.55.5.273

Methotrexate and liver toxicity: role of surveillance liver biopsy. Conflict between guidelines for rheumatologists and dermatologists.

W Hassan 1
PMCID: PMC1010158  PMID: 8660097

Full text

PDF
273

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aponte J., Petrelli M. Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate. Arthritis Rheum. 1988 Dec;31(12):1457–1464. doi: 10.1002/art.1780311201. [DOI] [PubMed] [Google Scholar]
  2. BAKER H., GOLDING D. N., THOMPSON M. Psoriasis and arthritis. Ann Intern Med. 1963 Jun;58:909–925. doi: 10.7326/0003-4819-58-6-909. [DOI] [PubMed] [Google Scholar]
  3. Boh L. E., Schuna A. A., Pitterle M. E., Adams E. M., Sundstrom W. R. Low-dose weekly oral methotrexate therapy for inflammatory arthritis. Clin Pharm. 1986 Jun;5(6):503–508. [PubMed] [Google Scholar]
  4. Brick J. E., Moreland L. W., Al-Kawas F., Chang W. W., Layne R. D., DiBartolomeo A. G. Prospective analysis of liver biopsies before and after methotrexate therapy in rheumatoid patients. Semin Arthritis Rheum. 1989 Aug;19(1):31–44. doi: 10.1016/0049-0172(89)90085-1. [DOI] [PubMed] [Google Scholar]
  5. Eastmond C. J. Psoriatic arthritis. Genetics and HLA antigens. Baillieres Clin Rheumatol. 1994 May;8(2):263–276. doi: 10.1016/s0950-3579(94)80018-9. [DOI] [PubMed] [Google Scholar]
  6. Espinoza L. R., Zakraoui L., Espinoza C. G., Gutiérrez F., Jara L. J., Silveira L. H., Cuéllar M. L., Martínez-Osuna P. Psoriatic arthritis: clinical response and side effects to methotrexate therapy. J Rheumatol. 1992 Jun;19(6):872–877. [PubMed] [Google Scholar]
  7. Kremer J. M., Alarcón G. S., Lightfoot R. W., Jr, Willkens R. F., Furst D. E., Williams H. J., Dent P. B., Weinblatt M. E. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Arthritis Rheum. 1994 Mar;37(3):316–328. doi: 10.1002/art.1780370304. [DOI] [PubMed] [Google Scholar]
  8. Kremer J. M., Lee R. G., Tolman K. G. Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples. Arthritis Rheum. 1989 Feb;32(2):121–127. doi: 10.1002/anr.1780320202. [DOI] [PubMed] [Google Scholar]
  9. Minocha A., Dean H. A., Pittsley R. A. Liver cirrhosis in rheumatoid arthritis patients treated with long-term methotrexate. Vet Hum Toxicol. 1993 Feb;35(1):45–48. [PubMed] [Google Scholar]
  10. Nyfors A. Liver biopsies from psoriatics related to methotrexate therapy. 3. Findings in post-methotrexate liver biopsies from 160 psoriatics. Acta Pathol Microbiol Scand A. 1977 Jul;85(4):511–518. doi: 10.1111/j.1699-0463.1977.tb03882.x. [DOI] [PubMed] [Google Scholar]
  11. Phillips C. A., Cera P. J., Mangan T. F., Newman E. D. Clinical liver disease in patients with rheumatoid arthritis taking methotrexate. J Rheumatol. 1992 Feb;19(2):229–233. [PubMed] [Google Scholar]
  12. Poikolainen K., Reunala T., Karvonen J., Lauharanta J., Kärkkäinen P. Alcohol intake: a risk factor for psoriasis in young and middle aged men? BMJ. 1990 Mar 24;300(6727):780–783. doi: 10.1136/bmj.300.6727.780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rademaker M., Webb J. A., Lowe D. G., Meyrick-Thomas R. H., Kirby J. D., Munro D. D. Magnetic resonance imaging as a screening procedure for methotrexate induced liver damage. Br J Dermatol. 1987 Sep;117(3):311–316. doi: 10.1111/j.1365-2133.1987.tb04137.x. [DOI] [PubMed] [Google Scholar]
  14. Rau R., Karger T., Herborn G., Frenzel H. Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate. J Rheumatol. 1989 Apr;16(4):489–493. [PubMed] [Google Scholar]
  15. Roenigk H. H., Jr, Auerbach R., Maibach H. I., Weinstein G. D. Methotrexate in psoriasis: revised guidelines. J Am Acad Dermatol. 1988 Jul;19(1 Pt 1):145–156. doi: 10.1016/s0190-9622(88)80237-8. [DOI] [PubMed] [Google Scholar]
  16. Shergy W. J., Polisson R. P., Caldwell D. S., Rice J. R., Pisetsky D. S., Allen N. B. Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis. Am J Med. 1988 Dec;85(6):771–774. doi: 10.1016/s0002-9343(88)80019-6. [DOI] [PubMed] [Google Scholar]
  17. Themido R., Loureiro M., Pecegueiro M., Brandão M., Campos M. C. Methotrexate hepatotoxicity in psoriatic patients submitted to long-term therapy. Acta Derm Venereol. 1992 Sep;72(5):361–364. [PubMed] [Google Scholar]
  18. Van Dooren-Greebe R. J., Kuijpers A. L., Mulder J., De Boo T., Van de Kerkhof P. C. Methotrexate revisited: effects of long-term treatment in psoriasis. Br J Dermatol. 1994 Feb;130(2):204–210. doi: 10.1111/j.1365-2133.1994.tb02901.x. [DOI] [PubMed] [Google Scholar]
  19. Whiting-O'Keefe Q. E., Fye K. H., Sack K. D. Methotrexate and histologic hepatic abnormalities: a meta-analysis. Am J Med. 1991 Jun;90(6):711–716. [PubMed] [Google Scholar]
  20. Willkens R. F., Leonard P. A., Clegg D. O., Tolman K. G., Ward J. R., Marks C. R., Greene M. L., Roth G. J., Jackson C. G., Cannon G. W. Liver histology in patients receiving low dose pulse methotrexate for the treatment of rheumatoid arthritis. Ann Rheum Dis. 1990 Aug;49(8):591–593. doi: 10.1136/ard.49.8.591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Zachariae H., Kragballe K., Søgaard H. Methotrexate induced liver cirrhosis. Studies including serial liver biopsies during continued treatment. Br J Dermatol. 1980 Apr;102(4):407–412. doi: 10.1111/j.1365-2133.1980.tb06553.x. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES